🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, claiming the firms hid safety concerns that the drug posed to pediatric neurological development.

The lawsuit arrives four weeks after President Donald Trump advocated an unverified association between consuming acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a statement, he stated they "deceived the public by gaining financially from pain and marketing drugs without regard for the dangers."

The manufacturer asserts there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to line their pockets," Paxton, a Republican, declared.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its online platform, the company also stated it had "consistently assessed the applicable studies and there is no credible data that indicates a verified association between using paracetamol and autism spectrum disorder."

Associations representing doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of investigation on the utilization of paracetamol in gestation, zero credible investigations has successfully concluded that the usage of acetaminophen in any period of gestation causes neurodevelopmental disorders in offspring," the association commented.

The court filing references recent announcements from the Trump administration in arguing the drug is allegedly unsafe.

Recently, the former president caused concern from health experts when he advised expectant mothers to "resist strongly" not to consume acetaminophen when ill.

The FDA then released a statement that medical professionals should think about restricting the usage of acetaminophen, while also stating that "a proven link" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had pledged in April to undertake "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a short period.

But experts warned that finding a single cause of autism spectrum disorder - believed by scientists to be the outcome of a intricate combination of inherited and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and disability that influences how persons encounter and engage with the world, and is identified using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for the Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism.

The lawsuit seeks to make the firms "remove any promotional materials" that asserts acetaminophen is secure for women during pregnancy.

This legal action parallels the grievances of a collection of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

Judicial authorities threw out the case, saying studies from the parents' expert witnesses was lacking definitive proof.